The downregulation of GAS5 was even more significant in the osteosarcoma patients with lung metastasis (p < 0.001 vs. controls and p < 0.01 vs. osteosarcoma patients with no metastasis) (Figure 1A). This evidence concerns the gene GAS5 and osteosarcoma.